Singapore: Eisai has entered into an exclusive license agreement with HUYA Bioscience International to develop and marke...
Singapore: Eisai Co., Ltd. announced that its European regional headquarters Eisai Europe Ltd. has received a positive o...
Singapore: St. Jude Medical, a global medical device company, has launched the Unify Quadra cardiac resynchronization th...
Tokyo: United Kingdom's Mallinckrodt plc has announced that INOmax (nitric oxide) for inhalation has received regulator...
Singapore: Thailand Center of Excellence for lifesciences has signed a pact with Mahidol University's Faculty of Enginee...
Singapore: Netherlands-based Norgine BV and Japanese drugmaker Takeda Pharmaceutical have announced the approval of the ...
Singapore: PeptiDream, Tokyo-based biopharmaceutical company, has entered into a multi-target discovery and optimization...
Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welf...
Singapore: 5th Shimadzu Global Pharma Summit 2015, the flagship event of Shimadzu that provides a platform for the globa...
Singapore: Eisai announced that regarding the acquisition of Chinese generic pharmaceutical company Liaoning TianYi Biol...
Singapore: Human Metabolome Technologies (HMT), the leading provider of capillary electrophoresis mass spectrometry (CE...
The top 10 pharmaceutical products being sold in the Japanese market, by both local and foreign players, contribute to a...
Singapore: Pfizer's Xeljanz (tofacitinib citrate) has received approval for the treatment of adults with rheumatoid arth...
Singapore: JASDAQ-listed R-Tech Ueno has decided to conduct collaborative research with a group led by professor Susumu ...
Taiho Pharmaceutical Co Ltd (TPC), a full-fledged oncology pharmaceutical company headquartered in Tokyo, has establishe...
Singapore: Japanese pharma giant Amgen Astellas BioPharma and Astellas Pharma recently announced the launch of their pro...
Within the Asia-Pacific region, Japan has maintained its leadership role as the largest pharmaceutical market, second on...
Singapore: Cubist Pharmaceuticals and Astellas Pharma entered into an agreement under which Cubist will obtain the right...
